Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old
- You have had an average pain level of at least 4 out of 10 in the two weeks before the trial
- You have experienced one or more traumatic events that are still causing you symptoms today
- You are currently experiencing symptoms of depression and/or anxiety
- You have been on a stable medication routine for at least 2 weeks
Who may not be able to join:
- You have an autoimmune condition or a long-term inflammatory disease
- You have a neurological condition or another serious medical illness
- You have been diagnosed with bipolar disorder, schizoaffective disorder, or schizophrenia
- You are currently having thoughts of suicide
- You have received EMDR therapy (a type of trauma-focused therapy) within the last two years
- You have used or been dependent on substances such as alcohol or drugs within the last month (smoking does not count)
- You are currently involved in a legal case or disability claim related to fibromyalgia (confirm with trial site)
- You have any metal implants in your head
- You are pregnant or have tested positive for pregnancy
- You have a skin condition such as psoriasis, eczema, or dermatitis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Benedikt L. Amann, M.D., Parc de Salut Mar
Phone: (0034)933268500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in severity and in pain intensity as measured by the Visual Analogue Scale (VAS); Change in physical impairment due to FM assessed by The Revised Fibromyalgia Impact Questionnaire (FIQ-R); Change in catastrophic thinking related to pain experiences assessed by the Pain Catastrophizing Scale (PCS); Change in the impact of fatigue as assessed by the Brief Fatigue Inventory (BFI); PTSD diagnosis assessed by the Global Evaluation of Posttraumatic Stress (EGEP-5); Complex PTSD diagnosis assessed by The International Trauma Questionnaire (ITQ); Change in PTSD symptoms as measured by the Postt...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.